Dr. Liming Wang 王黎明
Chief Physician
Department of Hepatobiliary Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of liver and biliary tract tumors, including primary liver cancer, gallbladder cancer, bile duct cancer, colorectal liver metastases, and splenic tumors. Expertise includes minimally invasive laparoscopic surgery, open surgery, and anatomical liver resection.
Dr. Wang graduated from Central South University Xiangya School of Medicine (Bachelor’s) and Peking Union Medical College (Master’s and PhD). As Chief Physician at the Cancer Hospital, Chinese Academy of Medical Sciences, Dr. Wang performs open and laparoscopic liver resections, radiofrequency ablation, and biliary reconstruction. Dr. Wang coordinates weekly multidisciplinary team discussions for complex liver metastases.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member, China Anti-Cancer Association Committee on Cancer Nutrition
- Standing Committee Member, Chinese Society of Integrative Medicine Committee on Nutrition
- Vice Chair, Youth Committee, Cross-Strait Medical and Health Exchange Association
Name order: in Chinese the family name comes first (Wang Liming). Papers usually list the name as Liming Wang or Wang L.
Selected publications
82 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Cancer Res Clin Oncol, 2026 (senior author): Correction: Should lymphadenectomy be recommended in radical surgery of intrahepatic cholangiocarcinoma patients? A retrospective study. PubMed 42773276
- Eur J Surg Oncol, 2026 (senior author): Lymph node metastasis, dissection efficacy, and prognostic differences between direct and incidental gallbladder carcinoma: A retrospective study. PubMed 41763088
- Biochim Biophys Acta Rev Cancer, 2025 (senior author): Anoikis and NETosis in colorectal cancer liver metastasis: the relationship and perspectives. PubMed 40744394
- Eur J Surg Oncol, 2025 (senior author): Combining traditional analysis and machine learning to predict early, middle, and long-term recurrence of intrahepatic cholangiocarcinoma. PubMed 40446770
- Cancer Cell Int, 2025 (senior author): Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment. PubMed 40205387
- J Cancer Res Clin Oncol, 2025 (senior author): Should lymphadenectomy be recommended in radical surgery of intrahepatic cholangiocarcinoma patients? A retrospective study. PubMed 40072624
- Eur J Gastroenterol Hepatol, 2024 (senior author): Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection. PubMed 39475782
- Microbiol Spectr, 2024 (senior author): Role of intestinal flora in the development of nonalcoholic fatty liver disease in children. PubMed 38189294
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion